I migliori medici di Immunoistochimica in Israele — TOP-5 medici

Professor Ofer Merimsky — oncologo di spicco, specializzato in tumori ossei, tessuti molli, mesotelioma, cancro ai polmoni e lesioni metastatiche al fegato e ai polmoni. È il capo del dipartimento di tumori dello scheletro e dei tessuti molli del Centro Medico Suraski (Ichilov, Tel Aviv) e guida l'Associazione degli Oncologi Clinici in Israele.

Competenze principali e vantaggi per i pazienti:

• Ampia esperienza clinica e pratica internazionale, inclusa formazione negli Stati Uniti, Francia e Israele, insegnamento all'Università di Gerusalemme — consente l'uso di metodi diagnostici e terapeutici all'avanguardia con elevata precisione.
• Metodologie oncologiche comprendono il trattamento di sarcomi, mesoteliomi, tumori dello scheletro e dei tessuti molli, nonché radioterapia e brachiterapia. I pazienti ricevono trattamenti completi anche in presenza di patologie tumorali rare e complesse.
• Autore di numerose pubblicazioni in riviste prestigiose, tra cui il New England Journal of Medicine (N Engl J Med), Annals of Oncology e pubblicazioni nel contesto della Società Europea di Oncologia Medica (European Society for Medical Oncology, ESMO) — garantisce ai pazienti l'accesso a metodologie moderne e basate sull'evidenza.
• Affiliazioni in associazioni internazionali — Society of Oncologists and Radiotherapists Israel, ASCO, EMSOS, CTOS — conferma la sua alta professionalità e garantisce l'accesso ai protocolli di trattamento più avanzati.
• I pazienti possono ricevere consigli a distanza attraverso consulenze online, rendendo l'assistenza dell'esperto accessibile da qualsiasi paese.

I pazienti apprezzano il professor Merimsky per la sua profonda conoscenza dell'oncologia, la capacità di scegliere schemi di trattamento individuali e l'attenzione scrupolosa, garantendo sicurezza e fiducia in tutte le fasi della terapia.

Dr. Gal Goldstein is a leading specialist in Pediatric Oncology and Hemato-Oncology at Hadassah Medical Center. He is the Head of the Pediatric Oncology and Hemato-Oncology Department at Hadassah Hospital Ein Kerem.

Dr. Goldstein has over 20 years of experience. He focuses on retinoblastoma, precision medicine, and haploidentical bone marrow transplantation. He graduated from Tel Aviv University. In 2019-2020, Forbes named him one of the best doctors in Israel.

Dr. Goldstein is a member of The Israel Society of Pediatric Hematology and Oncology, The Israeli Cancer Association, and The International Society of Pediatric Oncology. He is dedicated to advancing pediatric cancer care.

Professor Dina Ben-Yehuda is a leading oncohematologist in Israel. She directs the Hematology Department at Hadassah Medical Center. She founded the laboratory for molecular diagnostics of blood diseases. She is known for her research in malignant blood diseases, bone marrow transplantation, gene therapy, and immunology.

Prof. Ben-Yehuda completed her postgraduate training at Memorial Sloan-Kettering Cancer Center. She has led Hadassah’s hematology department since 2000. In 2017, she became the first woman to serve as Dean of the Hadassah School of Medicine. She has received the Danielle Sonnenfeld Foundation’s Healing with the Heart Award. She is also a member of several national and international hematology societies.

Dr. Polina Stepensky is a top specialist in pediatric bone marrow transplantation. She has over 20 years of experience and has performed more than 3,500 bone marrow transplants. Dr. Stepensky focuses on treating children with rare blood cancers.

She is highly respected by colleagues and patients. In 2018, Forbes named her one of the best doctors. Families trust her for advanced care in complex blood diseases.

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.